About MODULIGHT.BIO INC
Modulight Biotherapeutics is a biotechnology company developing a precision neuromodulation platform using optogenetics to treat severe neurological disorders. Their mission is to provide fast-acting, precise, and side-effect-free treatments for conditions such as seizures, tremors, and persistent pain.
Development of precision optogenetics platformResearch in optogenetic modulation of neurological disordersClinical studies for neuropathic pain treatmentIn-vivo research and computational research developmentCollaborative research with scientific partners
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MODULIGHT.BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.